Heike Mertsching

Author PubWeight™ 24.88‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Functional neointima characterization of vascular prostheses in human. Ann Thorac Surg 2004 2.01
2 First human transplantation of a bioengineered airway tissue. J Thorac Cardiovasc Surg 2004 1.94
3 Engineered liver-like tissue on a capillarized matrix for applied research. Tissue Eng 2007 1.19
4 Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation 2006 1.09
5 Biological vascularized matrix for bladder tissue engineering: matrix preparation, reseeding technique and short-term implantation in a porcine model. J Urol 2005 0.96
6 Construction of autologous human heart valves based on an acellular allograft matrix. Circulation 2002 0.95
7 Porcine endogenous retrovirus released by a bioartificial liver infects primary human cells. Liver Int 2009 0.92
8 Experimental generation of a tissue-engineered functional and vascularized trachea. J Thorac Cardiovasc Surg 2004 0.91
9 Androgen and estrogen receptors in the human corpus cavernosum penis: immunohistochemical and cell culture results. World J Urol 2003 0.90
10 Isolation of primary endothelial and stromal cell cultures of the corpus cavernosum penis for basic research and tissue engineering. Eur Urol 2005 0.85
11 Influence of scaffold thickness and scaffold composition on bioartificial graft survival. Biomaterials 2003 0.85
12 Functional tissue engineering of autologous tunica albuginea: a possible graft for Peyronie's disease surgery. Eur Urol 2004 0.84
13 Tissue remodeling in a bioartificial fibromuscular patch following transplantation in a human. Transplantation 2005 0.82
14 In vivo repopulation of xenogeneic and allogeneic acellular valve matrix conduits in the pulmonary circulation. Ann Thorac Surg 2003 0.81
15 Guided tissue regeneration: porcine matrix does not transmit PERV. Biomaterials 2004 0.80
16 The potential of bioartificial tissues in oncology research and treatment. Onkologie 2007 0.80
17 Tissue engineering of viable pulmonary arteries for surgical correction of congenital heart defects. Ann Thorac Surg 2006 0.79
18 Expansion of chondrocytes in a three-dimensional matrix for tracheal tissue engineering. Ann Thorac Surg 2004 0.78
19 In vivo model for cross-species porcine endogenous retrovirus transmission using tissue engineered pulmonary arteries. Eur J Cardiothorac Surg 2003 0.78
20 Role of inflammation in allogeneic and xenogeneic heart valve degeneration: immunohistochemical evaluation of inflammatory endothelial cell activation. J Heart Valve Dis 2003 0.78
21 Europe's advanced therapy medicinal products: chances and challenges. Expert Rev Med Devices 2009 0.78
22 Tissue engineering human small-caliber autologous vessels using a xenogenous decellularized connective tissue matrix approach: preclinical comparative biomechanical studies. Artif Organs 2011 0.77
23 Preclinical assessment of a tissue-engineered vasomotive human small-calibered vessel based on a decellularized xenogenic matrix: histological and functional characterization. Tissue Eng Part A 2011 0.77
24 Cytotoxicity of different intracavernous vasoactive drugs on cultured endothelial cells of human corpus cavernosum penis. Urology 2004 0.77
25 Replacement of the trachea with an autologous aortic graft. Ann Thorac Surg 2004 0.77
26 A multifunctional bioreactor for three-dimensional cell (co)-culture. Biomaterials 2005 0.76
27 Experimental tracheal patching using extracellular matrix scaffolds. Ann Thorac Surg 2009 0.75
28 [Differentiation potential of human stem cells--approaches to tissue engineering and to cell transplantation]. Z Arztl Fortbild Qualitatssich 2002 0.75
29 Could 37 degrees C storage temperature extend homovital valve allograft viability? J Heart Valve Dis 2004 0.75
30 In vitro viability of human cavernosal endothelial and fibroblastic cells after exposure to papaverine/phentolamine and prostaglandin E1. BJU Int 2005 0.75
31 A novel small-animal model for accelerated investigation of tissue-engineered aortic valve conduits. Tissue Eng Part C Methods 2010 0.75
32 [Is chronic graft rejection the reason for degenerative changes in allogeneic and xenogeneic heart valve prostheses: immunohistochemical evaluation of inflammatory factors]. Z Kardiol 2002 0.75